Investigating how a specific micro-RNA can enhance antibiotic effectiveness against lung infections.
Let-7b in Extracellular Vesicles Secreted by Bronchial Epithelial Cells Increases the Antibiotic Sensitivity of Pseudomonas
This study is looking at how a tiny molecule called let-7b, made by lung cells, can help make the bacteria that cause infections in people with chronic lung conditions, like COPD and cystic fibrosis, more sensitive to antibiotics, which could lead to better treatments for these patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Dartmouth College NIH-funded |
| Lab location | 1 site (Hanover, United States) |
| Project ID | NIH-10745953 on NIH RePORTER |
What this research studies
This research focuses on the role of let-7b, a micro-RNA secreted by bronchial epithelial cells, in increasing the sensitivity of the bacteria Pseudomonas aeruginosa to antibiotics. By studying how let-7b affects the bacteria's ability to form biofilms and resist treatment, the research aims to uncover new mechanisms of host-pathogen interactions in the lungs. Patients with chronic lung conditions, such as COPD and cystic fibrosis, may particularly benefit from understanding how this micro-RNA can enhance antibiotic efficacy. The research employs advanced techniques to analyze the interactions between let-7b and Pseudomonas, potentially leading to improved treatment strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with chronic obstructive pulmonary disease (COPD), cystic fibrosis, or recurrent bacterial lung infections.
Not a fit: Patients without chronic lung conditions or those not infected with Pseudomonas aeruginosa may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for lung infections, particularly in patients with chronic respiratory diseases.
How similar studies have performed: Previous studies have shown promising results in enhancing antibiotic sensitivity through micro-RNAs, suggesting that this approach may be effective.
Where this research is happening
Hanover, United States
- Dartmouth College — Hanover, United States (Active)
Researchers
- Principal investigator: Stanton, Bruce a. — Dartmouth College
- Study coordinator: Stanton, Bruce a.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.